My Queue

There are no Videos in your queue.

Click on the Add to next to any video to save to your queue.

There are no Articles in your queue.

Click on the Add to next to any article to save to your queue.

There are no Podcasts in your queue.

Click on the Add to next to any podcast episode to save to your queue.

You're not following any authors.

Click the Follow button on any author page to keep up with the latest content from your favorite authors.

News and Trends / Business News

Jordanian Pharmaceutical Company Replaces Tullow Oil on FTSE 100

Jordanian Pharmaceutical Company Replaces Tullow Oil on FTSE 100
Image credit: Shutterstock
1 min read

You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media.

Hikma Pharmaceuticals is now the fourth pharmaceutical company to make it on the FTSE 100 Index. Owned by the London Stock Exchange, the FTSE 100 is a quarterly index that lists the London Stock Exchange’s top 100 companies, in terms of its market capitalization. Hikma Pharmaceuticals’ market value is at almost 4.9 billion British pounds, knocking off Tullow Oil, due to its value shrinking from £4.6 billion to £3.3 billion as a result of declining oil prices. Hikma Pharmaceuticals have enjoyed a 21% rise in profits, and have now been discussing terms for potential dollar bonds with Citigroup, Barclays, HSBC, and National Bank of Abu Dhabi.